Bioceres Crop Solutions (NasdaqGS:BIOX) Q4 2025 Earnings Call September 09, 2025 08:30 AM ET Company ParticipantsPaula Savanti - Head of IRFederico Trucco - CEOOperatorWelcome all to the Bioceres Crop Solutions Fiscal Fourth Quarter and Full Year 2025 financial results. My name is Drew, and I'll be the operator on the call today. During the call, we will have a Q&A session after the prepared remarks. If you would like to register for a question, please press star followed by one on your telephone keypad. If ...

Core Viewpoint - The company, Andermatt A (000553.SZ), confirmed that its main business focuses on crop protection products and does not involve any antibiotic-related business [2] Company Summary - Andermatt A's primary business is in crop protection products [2] - The company does not engage in the antibiotic sector [2]

Group 1 - The global crop protection product inventory levels are showing signs of normalization after an unprecedented destocking in 2023, with manufacturers cautiously optimistic about the market in the second half of 2025 [2] - The global crop protection market is expected to decline by 6.0% year-on-year in 2024, reaching approximately $75.4 billion, due to macroeconomic factors and low agricultural prices affecting farmer incomes [2] - Crop protection companies have faced challenges over the past two years, with executives acknowledging the difficult period for the industry, but there are expectations for performance improvement in 2025 due to stabilized inventory and demand recovery [2] Group 2 - The U.S. crop protection market is projected to grow by 2.1% in 2025, reaching $77 billion, despite ongoing inflation and trade tensions impacting farmer incomes [3] - Tariff impacts on crop protection companies have been manageable, with estimates of tariff effects on Corteva's crop protection business reduced from $50 million to $25-30 million, aided by supply chain diversification [3] - U.S. farmers are proceeding with their planting plans, which is a positive sign for the crop protection market recovery [3] Group 3 - European crop protection companies face greater challenges, with Bayer anticipating increased price competition due to a surge in generic product capacity, particularly in glyphosate [4] - Bayer has announced a restructuring of its crop protection production and R&D in Germany to address the competitive pressures from Asian generic manufacturers [4]

Core Viewpoint - Company expects a significant reduction in losses for the first half of 2025 compared to the same period in 2024, with a projected net loss of between 54 million to 108 million yuan [1][2]. Financial Performance - The company anticipates a year-on-year reduction in losses primarily due to an increase in operating profit and a decrease in tax expenses, which outweighed the impact of rising financial costs [2]. - EBITDA and its profit margin are expected to grow year-on-year compared to the same period in 2024, driven by improvements in gross profit and gross margin, reflecting lower inventory costs and increased sales volume [2]. - The company projects that its sales for the first half of 2025 will remain stable compared to 2024, with a 1% increase in sales when calculated in RMB, while remaining flat in USD [2][3]. Strategic Transformation - The company is undergoing a significant transformation to address challenges in the agricultural chemical industry, including oversupply issues. The "Advancement" transformation plan, initiated in early 2024, aims to enhance profits and improve cash flow over three years [4]. - The "Advancement" plan consists of three main pillars: optimizing financial management, streamlining operational structure, and focusing on "value innovation" in niche markets [4]. - The management has indicated that the transformation plan has positively impacted key financial metrics, including EBITDA, EBITDA margin, cash flow, and overall operating expenses [4][5]. Operational Efficiency - The company is implementing cost optimization measures to lower operating costs and improve financial health, alongside transforming its operational model for greater efficiency [5]. - The company has removed several low-margin products from its portfolio to enhance profitability [6]. - Over the past year, the company's stock price has increased by nearly 70% [6].